La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cachet Pharmaceutical Bilan de santé
Santé financière contrôle des critères 6/6
Cachet Pharmaceutical has a total shareholder equity of CN¥6.2B and total debt of CN¥3.1B, which brings its debt-to-equity ratio to 49.7%. Its total assets and total liabilities are CN¥16.1B and CN¥9.9B respectively. Cachet Pharmaceutical's EBIT is CN¥728.8M making its interest coverage ratio 5.8. It has cash and short-term investments of CN¥2.9B.
Informations clés
49.7%
Ratio d'endettement
CN¥3.08b
Dette
| Ratio de couverture des intérêts | 5.8x |
| Argent liquide | CN¥2.85b |
| Fonds propres | CN¥6.20b |
| Total du passif | CN¥9.88b |
| Total des actifs | CN¥16.08b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Analyse de la situation financière
Passif à court terme: 002462's short term assets (CN¥14.6B) exceed its short term liabilities (CN¥9.7B).
Passif à long terme: 002462's short term assets (CN¥14.6B) exceed its long term liabilities (CN¥187.8M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 002462's net debt to equity ratio (3.7%) is considered satisfactory.
Réduire la dette: 002462's debt to equity ratio has reduced from 98.7% to 49.7% over the past 5 years.
Couverture de la dette: 002462's debt is well covered by operating cash flow (37.9%).
Couverture des intérêts: 002462's interest payments on its debt are well covered by EBIT (5.8x coverage).